Venrock Adviser, LLC’s Relmada Therapeutics Inc Position
Does Venrock Adviser, LLC own Relmada Therapeutics Inc (RLMD)? Yes — 4.84M shares worth $34M (+1.26% of its 13F portfolio) as of Q1 2026, up from 1.52M shares the prior filed quarter.
Position Value
$34M
Q1 2026
Shares
4.84M
% of Portfolio
+1.26%
Quarters Held
12
currently held
Position History RLMD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 4.84M | $34M | +1.26% |
| Q3 2022 | 1.52M | $56M | +8.26% |
| Q2 2022 | 2.27M | $43M | +7.78% |
| Q1 2022 | 2.27M | $61M | +9.93% |
| Q4 2021 | 2.27M | $51M | +6.99% |
| Q3 2021 | 1.39M | $36M | +4.67% |
| Q2 2021 | 1.39M | $44M | +5.39% |
| Q1 2021 | 853.2K | $30M | +3.26% |
| Q4 2020 | 668.4K | $21M | +3.15% |
| Q3 2020 | 668.4K | $25M | +4.92% |
| Q2 2020 | 668.4K | $30M | +7.16% |
| Q1 2020 | 842.8K | $29M | +7.79% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venrock Adviser, LLC’s full portfolio or all institutional holders of RLMD.